Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2017, Vol. 37 Issue (2): 8-14    DOI: 10.13523/j.cb.20170202
    
Effects of S100A6 on Proliferation and Migration of Human Cervical Cancer Cells and Its Mechanism
LI Ai-fang, GU Yue, LI Xue-ru, SUN Hui, ZHA He, XIE Jia-qing, ZHAO Jia-li, ZHOU Lan
Key Laboratory of Laboratory Medical Diagnostics of Ministry of Education, Chongqing Medical University, Chongqing 400016, China
Download: HTML   PDF(876KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective: To investigate the effects of S100A6 on cell proliferation and migration of cervical cancer cells and explore its mechanism. Methods: Quantitative polymerase chain reaction (qPCR) was used to detect the basic expression of S100A6 in HeLa, SiHa and CaSki cells; HeLa and SiHa cells were treated with recombinant adenoviruses AdS100A6 and AdsiS100A6 to upregulate and downregulate S100A6 expression respectively, Western blot was used to verify the effects of virus infection. MTT method was used to detect cell proliferation ability; wound healing assay was used to detect cell migration ability; Western blot was used to detect the level of E-cadherin, N-cadherin and p-Akt; reverse transcription and polymerase chain reaction(RT-PCR) was used to detect the level of Snail and Twist, the downstream target genes of PI3K-Akt pathway. Results: In AdS100A6 group (HeLa cells), the OD492 value and wound healing rate at the 3rd day were increased, N-cadherin was increased, but E-cadherin was decreased; In AdsiS100A6 group (SiHa cells), the OD492 value at the 5th day and wound healing rate at the 3rd day were decreased, N-cadherin was decreased, but E-cadherin was increased; At the same time, in AdS100A6 group, p-Akt was increased, Snail and Twist were also increased obviously. Conclusion: S100A6 promotes cervical cancer cells proliferation and migration and the effect may be mediated by inducing epithelial-mesenchymal transition and activating PI3K/Akt signaling pathway.



Key wordsPI3K/Akt signaling pathway      Cervical cancer      S100A6      Epithelial-mesenchymal transition     
Received: 28 July 2016      Published: 25 February 2017
ZTFLH:  Q819  
Cite this article:

LI Ai-fang, GU Yue, LI Xue-ru, SUN Hui, ZHA He, XIE Jia-qing, ZHAO Jia-li, ZHOU Lan. Effects of S100A6 on Proliferation and Migration of Human Cervical Cancer Cells and Its Mechanism. China Biotechnology, 2017, 37(2): 8-14.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20170202     OR     https://manu60.magtech.com.cn/biotech/Y2017/V37/I2/8

[1] Zur Hausen H. Papillomaviruses and cancer:from basic studies to clinical application. Nature Reviews Cancer, 2002, 2(5):342-350.
[2] Das B C, Hussain S, Nasare V, et al. Prospects and prejudices of human papillomavirus vaccines in India. Vaccine, 2008, 26(22):2669-2679.
[3] Chen H, Xu C, Jin Q, et al. S100 protein family in human cancer. American Journal of Cancer Research, 2014, 4(2):89-115.
[4] Heizmann C W, Fritz G, Schafer B W. S100 proteins:structure, functions and pathology. Frontiers in Bioscience, 2002, 7:1356-1368.
[5] Duan L, Wu R, Zou Z, et al. S100A6 stimulates proliferation and migration of colorectal carcinoma cells through activation of the MAPK pathways. International Journal of Oncology, 2014, 44(3):781-790.
[6] Chen X, Liu X, Lang H, et al. S100 calcium-binding protein A6 promotes epithelial-mesenchymal transition through beta-catenin in pancreatic cancer cell line. PloS One, 2015, 10(3):e0121319.
[7] Wang X H, Zhang L H, Zhong X Y, et al. S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer. The American Journal of Pathology, 2010, 177(2):586-597.
[8] Li Z, Tang M, Ling B, et al. Increased expression of S100A6 promotes cell proliferation and migration in human hepatocellular carcinoma. Journal of Molecular Medicine 2014, 92(3):291-303.
[9] Li Y, Wagner E R, Yan Z, et al. The Calcium-binding protein S100A6 accelerates human osteosarcoma growth by promoting cell proliferation and inhibiting osteogenic differentiation. Cellular Physiology and Biochemistry:International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 2015, 37(6):2375-2392.
[10] 谭媛,姚德生.S100A6在宫颈癌组织中的表达及其意义,中国现代医生,2010, 48 (11):9-10. Tan Y, Yao D S. Expression and role of A100A6 in cervical cancer. China Mordern Doctor. 2010, 48 (11):9-10.
[11] Das B C, Tyagi A, Vishnoi K, et al. Cervical cancer stem cells selectively overexpress HPV oncoprotein E6 that controls stemness and self renewal through upregulation of HES1. Clinical Cancer Research, 2016, 22 (16):4170-4184.
[12] 游莉, 徐兰兰, 郭元元, 等. 重组人S100A6促进人乳腺癌细胞MCF-7的增殖和迁移侵袭并抑制其凋亡, 中国细胞生物学学报, 2011, 33 (7):746-751. You L, Xu L L, Guo Y Y, et al. Recombinant human S100A6 promotes the proliferation, migration and invasion but inhibits the apoptosis of human breast cancer cell line MCF-7. Chinese Journal of Cell Biology, 2011, 33 (7):746-751.
[13] 王海燕, 邹正渝, 段亮, 等. S100A6通过PI3K_Akt信号通路促进人骨肉瘤细胞143B增殖和迁移, 中国病理生理杂志, 2013, 29 (11):1928-1933. Wang H Y, Zou Z Y, Duan L, et al. S100A6 promotes proliferation and migration of human osteosarcoma cell 143B through PI3K/Akt signaling pathway. Chinese Journal of Pathophysiology, 2013, 29 (11):1928-1933.
[14] Ansieau S, Courtois-Cox S, Morel A P, et al. Failsafe program escape and EMT:a deleterious partnership. Seminars in Cancer Biology, 2011, 21(6):392-396.
[15] 刘海霞, 陈必良, 李佳, 等. EMT参与肿瘤侵袭转移的研究进展, 现代生物医学进展, 2014, 14 (14):2790-2793. Liu H X, Chen B L, Li J, et al. The research progress of EMT in tumor invasion and migration. Progress in Modern Biomedcine. 2014, 14 (14):2790-2793.
[16] Grille S J, Bellacosa A, Upson J, et al. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Research, 2003, 63(9):2171-2178.
[17] Liangru Ke, Xiang Yanqun, Guo Xiang. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K_Akt signaling pathway——a new and promising target for NPC. Oncotarget, 2016,7 (19):28340-28355.
[18] Shu X R, Wu J, Sun H, et al. PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway. Diagnostic Pathology, 2015, 10:177.
[19] 李雪茹,孙晖,查何,等. S100A9对宫颈癌Hela细胞的增殖和迁移的影响及其机制探讨. 中国细胞生物学学报, 2015, 37(12):1632-1638. Li X R, Sun H, Zha H, et al. The effects of S100A9 on proliferation and migration of human squamous cervical carcinoma hela cell line and its mechanisms. Chinese Journal of Cell Biology, 2015, 37(12):1632-1638.

[1] LU Yu-xiang,LI Yuan,FANG Dan-dan,WANG Xue-bo,YANG Wan-peng,CHU Yuan-kui,YANG Hua. The Role and Expression Regulation of MiR-5047 in the Proliferation and Migration of Breast Cancer Cells[J]. China Biotechnology, 2021, 41(4): 9-17.
[2] XU An-jian,LI Yan-meng,WU Shan-na,ZHANG Bei,YAO Jing-yi. PHP14 Plays a Role in Epithelial-Mesenchymal Transition of AML-12Cell Through Interaction with Vimentin[J]. China Biotechnology, 2021, 41(2/3): 1-6.
[3] LIN Lu,HU Li-jun,HUANG Yi-yun,CHEN Lu,HUANG Mao,PENG Qi,HU Qin,ZHOU Lan. S100A6 Promotes Angiogenesis Through Recruiting and Activating Macrophages[J]. China Biotechnology, 2020, 40(5): 7-14.
[4] TANG Min,WAN Qun,SUN Shi-lei,HU Jing,SUN Zi-jiu,FANG Yu-ting,ZHANG Yan. The Effects of Hsa-miR-5195-3p on the Proliferation, Migration and Invasion of Human Cervical Cancer SiHa Cells[J]. China Biotechnology, 2020, 40(4): 17-24.
[5] FENG Xue-jiao,HOU Hai-long,YU Qiong,WANG Jun-shu. Market Analysis and Countermeasures of Cervical Cancer Vaccine in China[J]. China Biotechnology, 2020, 40(11): 96-101.
[6] Lu CHEN,Mao HUANG,Qi PENG,Jia-li ZHAO,Jia-qing XIE,Lu LIN,Li-jun HU,Yi-yun HUANG,Qin HU,Lan ZHOU. S100A6 Promotes Cell Proliferation of Colorectal Cancer via Upregulating IL-6 Expression of Macrophages[J]. China Biotechnology, 2019, 39(4): 1-7.
[7] SUN Hui, LI Xue-ru, ZHA He, DUAN Liang, YUAN Shi-mei, LI Huan, LI Ai-fang, GU Yue, ZHOU Lan. Effect of Exogenous S100A6 Protein on The Level of S100A6 mRNA of Colorectal Carcinoma Cell Lines and Its Possible Mechanism[J]. China Biotechnology, 2016, 36(1): 14-22.
[8] XIN Jing, XU Yin-sheng, ZHANG Fang, SHENG Wang. The Function and Mechanism of MicroRNA-124 in Human Cervical Cancer[J]. China Biotechnology, 2015, 35(10): 13-19.
[9] ZOU Zheng-yu, WANG Hai-yan, LI Yu-ye, SUN Shuang-shuang, YE Li-wei, WU Rui, DUAN Liang, CHEN Xian, LUO Jin-yong, ZHOU Lan. Prokaryotic Expression of Recombinant Protein HS100A6 and Its Biological Effects on Human Osteosarcoma Cell Line 143B[J]. China Biotechnology, 2012, 32(12): 1-7.
[10] LI Yu-ye, LI Xing-xing, SUN Shuang-shuang, ZOU Zheng-yu, ZHANG Yun-yuan, DUAN Liang, YE Li-wei, WU Rui, YANG Xia, HE Tong-chuan, ZHOU Lan. Effects and Possible Mechanism of Protein S100A6 on β-catenin[J]. China Biotechnology, 2011, 31(11): 18-23.
[11] . Advance in HPV vaccine[J]. China Biotechnology, 2007, 27(4): 104-109.
[12] . The Construction, Expression and Purification of Therapeutic Adjuvant-free protein Vaccine—HPV16Z-Hsp65-E6/E7[J]. China Biotechnology, 2006, 26(12): 40-44.